This page provides general guidance only. Aviation medical decisions are made on a case-by-case basis by Transport Canada and a CAME.
Medications are assessed according to Transport Canada Civil Aviation Medicine guidance (SI 404-005). Both the underlying condition and effects of the medication are considered for flight safety.
Type a medication name to see general aviation guidance.
These medications are generally not compatible with aviation safety. CAMEs may not renew a pilot on these medications unless previously approved and stable. If stopped, a washout period is required (typically ≥5 half-lives, may vary by drug).
Rule of thumb: If you take any of these medications, consult a CAME before flying. Special protocols may exist in rare cases.
These are typically compatible with aviation if the underlying condition is stable, the medication is tolerated, and ground testing shows no impairment:
Even low-risk medications require CAME documentation of stability, dose, and absence of side effects.